Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease.

Title : Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease

Source : PubMed
ID : 30819552
Authors : Picard, Fabien; Bhatt, Deepak L.; Ducrocq, Gregory; Elbez, Yedid; Ferrari, Roberto; Ford, Ian; Tardif, Jean Claude; Tendera, Michal; Fox, Kim M.; Steg, Philippe Gabriel
Year : 2019
Disease Category : Cardiovascular diseases
Focused Population : Elderly patients
Priori/Posteriori : Posteriori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Trial participants vs. eligible patients (by applying eligibility criteria on the patient data) : Yes
Real-world data sources : The CLARIFY (ProspeCtive observational Longitudinal RegIstry of patients with stable coronary arterY disease) registry
Target Population Data Type Levels : International